Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Iovance Biotherapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 244
- +11 vs. Q2 2021
- Shares held
- 158.0M
- −4.05M (−2.5%) vs. Q2 2021
- Total value
- $3.88B
- −$329.9M (−7.8%) vs. Q2 2021
- New holders
- 34
- 92 more added
- Sold out
- 23
- 89 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 621,039 | $15.3M | 0.02% | −194,809−23.9% | Reduced |
| Northern Trust Corp | 622,214 | $15.3M | 0.00% | −37,492−5.7% | Reduced |
| New York State Common Retirement Fund | 631,553 | $15.6M | 0.02% | −21,678−3.3% | Reduced |
| Voloridge Investment Management, LLC | 638,434 | $15.7M | 0.10% | −55,183−8.0% | Reduced |
| Charles Schwab Investment Management Inc | 665,896 | $16.4M | 0.01% | −89,520−11.9% | Reduced |
| Frontier Capital Management Co LLC | 676,942 | $16.7M | 0.13% | −337,871−33.3% | Reduced |
| QVT Financial LP | 678,564 | $16.7M | 1.32% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 700,000 | $17.3M | 5.69% | +250,000+55.6% | Added |
| Novo Holdings A/S | 836,518 | $20.6M | 1.07% | +161,358+23.9% | Added |
| Candriam Luxembourg S.C.A. | 848,652 | $20.9M | 0.14% | −171,774−16.8% | Reduced |
| Rice Hall James & Associates, LLC | 861,947 | $21.3M | 0.79% | −21,448−2.4% | Reduced |
| Lombard Odier Asset Management (Switzerland) SA | 869,540 | $21.4M | 1.33% | +80,978+10.3% | Added |
| 683 Capital Management, LLC | 949,829 | $23.4M | 1.21% | −75,000−7.3% | Reduced |
| Balyasny Asset Management LLC | 963,460 | $23.8M | 0.11% | +354,336+58.2% | Added |
| Pictet Asset Management SA | 998,075 | $24.6M | 0.03% | +998,075 | New |
| Invesco Ltd. | 1,026,657 | $25.3M | 0.01% | −7,708−0.7% | Reduced |
| Boxer Capital, LLC | 1,100,000 | $27.1M | 0.95% | +1,100,000 | New |
| Norges Bank | 1,238,198 | $30.5M | 0.01% | +52,525+4.4% | Added |
| Goldman Sachs Group Inc | 1,255,100 | $31.0M | 0.01% | −387,478−23.6% | Reduced |
| Citadel Advisors LLC | 1,353,563 | $33.4M | 0.04% | −1,024,101−43.1% | Reduced |
| Assenagon Asset Management S.A. | 1,457,308 | $35.9M | 0.15% | −22,411−1.5% | Reduced |
| Avidity Partners Management LP | 1,462,200 | $36.1M | 0.92% | +1,462,200 | New |
| JPMorgan Chase & Co | 1,638,736 | $40.4M | 0.01% | +223,729+15.8% | Added |
| Bank of New York Mellon Corp | 1,718,933 | $42.4M | 0.01% | −20,842−1.2% | Reduced |
| Geode Capital Management, LLC | 1,786,012 | $44.0M | 0.01% | −43,224−2.4% | Reduced |
| FMR LLC | 1,950,618 | $48.1M | 0.00% | −727,541−27.2% | Reduced |
| Ameriprise Financial Inc | 2,171,600 | $53.6M | 0.02% | +885,153+68.8% | Added |
| Credit Suisse AG | 2,415,613 | $59.6M | 0.05% | +3,410+0.1% | Added |
| Frazier Management LLC | 2,674,299 | $65.9M | 5.28% | +536,300+25.1% | Added |
| Artisan Partners Limited Partnership | 2,868,295 | $70.7M | 0.09% | −106,039−3.6% | Reduced |
| Armistice Capital, LLC | 3,648,000 | $90.0M | 2.22% | +276,000+8.2% | Added |
| State Street Corp | 4,388,106 | $108.2M | 0.01% | +445,433+11.3% | Added |
| Price T Rowe Associates Inc | 4,624,728 | $114.0M | 0.01% | −25,824−0.6% | Reduced |
| Farallon Capital Management, L.L.C. | 5,339,994 | $131.7M | 0.71% | +89,994+1.7% | Added |
| Nikko Asset Management Americas, Inc. | 6,380,803 | $145.0M | 0.62% | −1,343,985−17.4% | Reduced |
| Franklin Resources Inc | 6,269,423 | $154.6M | 0.06% | −957,650−13.3% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 6,380,803 | $157.4M | 0.10% | −1,356,815−17.5% | Reduced |
| OrbiMed Advisors LLC | 6,645,100 | $163.9M | 1.82% | 00.0% | Unchanged |
| BlackRock Inc. | 6,947,806 | $171.3M | 0.00% | +179,637+2.7% | Added |
| Avoro Capital Advisors LLC | 8,500,000 | $209.6M | 3.30% | −600,000−6.6% | Reduced |
| Wellington Management Group LLP | 8,899,530 | $219.5M | 0.04% | +1,648,287+22.7% | Added |
| Perceptive Advisors LLC | 11,489,772 | $283.3M | 4.13% | +530,000+4.8% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 11,649,837 | $287.3M | 0.69% | −6,800,876−36.9% | Reduced |
| Vanguard Group Inc | 11,928,989 | $294.2M | 0.01% | −307,422−2.5% | Reduced |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −468,538−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −370,260−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −134,046−100.0% | Sold out |
| King Luther Capital Management Corp | 0 | $0 | 0.00% | −114,210−100.0% | Sold out |
| DSAM Partners (London) Ltd | 0 | $0 | 0.00% | −81,627−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −60,046−100.0% | Sold out |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −46,419−100.0% | Sold out |
| Discovery Value Fund | 0 | $0 | 0.00% | −35,437−100.0% | Sold out |
| Premier Asset Management LLC | 0 | $0 | 0.00% | −28,760−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −17,867−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −11,131−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −11,073−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −9,391−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −8,888−100.0% | Sold out |
| Claraphi Advisory Network, LLC | 0 | $0 | 0.00% | −8,218−100.0% | Sold out |
| Kalos Management, Inc. | 0 | $0 | 0.00% | −8,450−100.0% | Sold out |
| Crestwood Advisors Group LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Checchi Capital Advisers, LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −3,336−100.0% | Sold out |
| Adirondack Trust Co | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| Private Capital Group, LLC | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Wexford Capital LP | – | – | – | – | Not filed |